Skip to main content
. 2004 Feb;24(3):945–953. doi: 10.1128/MCB.24.3.945-953.2004

FIG. 3.

FIG. 3.

In vitro cleavage of the CLB2 5′-UTR by RNase MRP. (A) Internally labeled RNA substrates containing the rRNA A3 cleavage site (positive control), the CLB2 5′-UTR or the 5.8S rRNA (noncleaved control RNA) were generated. Highly pure yeast RNase MRP was purified with the TAP tag protocol and used in a standard RNase MRP in vitro assay (3, 22). (B) The schematic indicates the source of the RNA substrates and the sizes of the RNAs.

HHS Vulnerability Disclosure